Yesterday, Jan. 27, 2016, 30 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $999.60 to $14,067,468.67.

Highlighted Stocks Traded by Insiders:

Brinker International (EAT) - FREE Research Report

Taylor Joseph G, who is VP, Corp. Affairs & Inv. Rel. at Brinker International, sold 1,000 shares at $50.12 on Jan. 27, 2016. Following this transaction, the VP, Corp. Affairs & Inv. Rel. owned 992 shares meaning that the stake was reduced by 50.2% with the 1,000-share transaction.

The shares most recently traded at $48.85, down $1.27, or 2.61% since the insider transaction. Historical insider transactions for Brinker International go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 7,500
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 7,500
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 44,445

The average volume for Brinker International has been 1.2 million shares per day over the past 30 days. Brinker International has a market cap of $3.0 billion and is part of the services sector and leisure industry. Shares are up 3.82% year-to-date as of the close of trading on Wednesday.

Brinker International, Inc., together with its subsidiaries, engages in the ownership, development, operation, and franchise of casual dining restaurants worldwide. The stock currently has a dividend yield of 2.61%. The company has a P/E ratio of 15.1. Currently, there are 5 analysts who rate Brinker International a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EAT - FREE

TheStreet Quant Ratings

rates Brinker International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Brinker International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DexCom (DXCM) - FREE Research Report

Pacelli Steven Robert, who is EVP, Strategy & Corp. Dev. at DexCom, sold 10,300 shares at $73.24 on Jan. 27, 2016. Following this transaction, the EVP, Strategy & Corp. Dev. owned 205,914 shares meaning that the stake was reduced by 4.76% with the 10,300-share transaction.

The shares most recently traded at $70.09, down $3.15, or 4.49% since the insider transaction. Historical insider transactions for DexCom go as follows:

  • 4-Week # shares sold: 10,560
  • 12-Week # shares sold: 43,465
  • 24-Week # shares sold: 149,574

The average volume for DexCom has been 717,300 shares per day over the past 30 days. DexCom has a market cap of $6.0 billion and is part of the health care sector and health services industry. Shares are down 10.61% year-to-date as of the close of trading on Wednesday.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently, there are 13 analysts who rate DexCom a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXCM - FREE

TheStreet Quant Ratings

rates DexCom as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and disappointing return on equity. Get the full

DexCom Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cal-Maine Foods (CALM) - FREE Research Report

Poole James E, who is Director at Cal-Maine Foods, sold 2,000 shares at $49.07 on Jan. 27, 2016. Following this transaction, the Director owned 6,300 shares meaning that the stake was reduced by 24.1% with the 2,000-share transaction.

The shares most recently traded at $49.05, down $0.02, or 0.04% since the insider transaction. Historical insider transactions for Cal-Maine Foods go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 1,000
  • 24-Week # shares bought: 1,000

The average volume for Cal-Maine Foods has been 924,200 shares per day over the past 30 days. Cal-Maine Foods has a market cap of $2.2 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 7.83% year-to-date as of the close of trading on Wednesday.

Cal-Maine Foods, Inc. produces, grades, packages, markets, and distributes shell eggs. It offers specialty shell eggs, such as nutritionally enhanced, cage free, organic, and brown eggs under the Egg-Land's Best, Land O' Lake, Farmhouse, and 4-Grain brand names, as well as under private labels. The stock currently has a dividend yield of 6.23%. The company has a P/E ratio of 6.7. Currently, there is 1 analyst who rates Cal-Maine Foods a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CALM - FREE

TheStreet Quant Ratings

rates Cal-Maine Foods as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

Cal-Maine Foods Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.